(19)
(11) EP 2 726 464 A1

(12)

(43) Date of publication:
07.05.2014 Bulletin 2014/19

(21) Application number: 12731150.4

(22) Date of filing: 27.06.2012
(51) International Patent Classification (IPC): 
C07D 231/56(2006.01)
A61P 11/00(2006.01)
A61P 29/00(2006.01)
A61K 31/416(2006.01)
A61P 17/00(2006.01)
A61P 37/00(2006.01)
(86) International application number:
PCT/GB2012/051503
(87) International publication number:
WO 2013/001294 (03.01.2013 Gazette 2013/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 29.06.2011 US 201161502656 P

(71) Applicants:
  • Astrazeneca AB
    SE-151 85 Södertälje (SE)
  • Bayer Intellectual Property GmbH
    40789 Monheim (DE)

(72) Inventors:
  • ANDERSSON, Helena, Ingemo
    SE-151 85 Södertälje (SE)
  • CONWAY, Kelly, Yvonne
    Macclesfield Cheshire SK10 2NA (GB)
  • QUAYLE, Michael, John
    SE-431 Mölndal (SE)

(74) Representative: Curran, Clair et al
Ropes & Gray International LLP 5 New Street Square
London EC4A 3BF
London EC4A 3BF (GB)

   


(54) CRYSTALLINE FORM OF INDAZOLYL AMIDE DERIVATIVES FOR THE TREATMENT GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS